Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

85.25
-0.4300-0.50%
Post-market: 85.250.00000.00%19:21 EDT
Volume:583.18K
Turnover:49.78M
Market Cap:21.40B
PE:-15.45
High:86.04
Open:85.87
Low:84.78
Close:85.68
52wk High:124.00
52wk Low:79.52
Shares:251.00M
Float Shares:105.00M
Volume Ratio:0.67
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.5189
EPS(LYR):-5.5184
ROE:-5.88%
ROA:-3.56%
PB:0.97
PE(LYR):-15.45

Loading ...

Earnings Flash (BNTX) BioNTech Posts Q4 Adjusted Loss 0.33 Euro a Share

MT Newswires Live
·
Mar 10

BioNTech Q4 EPS $(0.38) Beats $(0.47) Estimate, Sales $1.056B Beat $889.480M Estimate

Benzinga
·
Mar 10

BioNTech Q4 2025 net loss hits EUR 305 million as revenue falls 24% to EUR 907.4 million

Reuters
·
Mar 10

Press Release: BioNTech Announces Fourth Quarter and Full Year 2025 Financial Results and Corporate Update

Dow Jones
·
Mar 10

Stock Track | BioNTech Plunges 6.21% in Pre-Market Ahead of Quarterly Earnings Report

Stock Track
·
Mar 10

BioNTech's Co-Founders to Launch New mRNA Company

MT Newswires Live
·
Mar 10

BioNTech announces plans for independent company to be established

TIPRANKS
·
Mar 10

BioNTech SE (BNTX) Receives a Buy from Morgan Stanley

TIPRANKS
·
Mar 10

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 09

BioNTech Expands Oncology Pipeline With New First‑in‑Human BNT3214 Cancer Trial

TIPRANKS
·
Mar 07

Biontech SE expected to post a loss of 4 cents a share - Earnings Preview

Reuters
·
Mar 06

Aroundtown SA (AT1) Receives a Buy from Warburg Research

TIPRANKS
·
Mar 05

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 05

Regulatory Shifts Cloud Arcturus Therapeutics’ Outlook as FDA Delays KOSTAIVE BLA and Demands New COVID-19 Efficacy Data

TIPRANKS
·
Mar 05

BioNTech Expands Infectious Disease Pipeline With New Mpox mRNA Vaccine Trial in Africa

TIPRANKS
·
Mar 05

Performance Shipping reports Q4 EPS 19c vs. 25c last year

TIPRANKS
·
Mar 04

BioNTech SE ADR Sheds 6.3%, Underperforms Market

Dow Jones
·
Mar 04

Earning Preview: BioNTech SE Q4 revenue is expected to decrease by 27.20%, and institutional views are bullish

Earnings Agent
·
Mar 03

De.mem Grants Performance Rights to Director Andreas Kroell

TIPRANKS
·
Mar 02

Synpulse Builds On 30‑Year Anniversary Momentum with APAC Leaders Andreas Mettenberger and Adrien Thonet Elevated to Partner

prnewswire
·
Mar 02